• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Glutamate receptor antagonism: neurotoxicity, anti-akinetic effects, and psychosis.

作者信息

Riederer P, Lange K W, Kornhuber J, Jellinger K

机构信息

Department of Psychiatry, University of Würzburg, Federal Republic of Germany.

出版信息

J Neural Transm Suppl. 1991;34:203-10. doi: 10.1007/978-3-7091-9175-0_26.

DOI:10.1007/978-3-7091-9175-0_26
PMID:1687783
Abstract

There is evidence to suggest that glutamate and other excitatory amino acids play an important role in the regulation of neuronal excitation. Glutamate receptor stimulation leads to a non-physiological increase of intracellular free Ca2+. Disturbed Ca2+ homeostasis and subsequent radical formation may be decisive factors in the pathogenesis of neurodegenerative diseases. Decreased glutamatergic activity appears to contribute to paranoid hallucinatory psychosis in schizophrenia and pharmacotoxic psychosis in Parkinson's disease. It has been suggested that a loss of glutamatergic function causes dopaminergic over-activity. Imbalances of glutamatergic and dopaminergic systems in different brain regions may result in anti-akinetic effects or the occurrence of psychosis. The simplified hypothesis of a glutamatergic-dopaminergic (im)-balance may lead to a better understanding of motor behaviour and psychosis.

摘要

相似文献

1
Glutamate receptor antagonism: neurotoxicity, anti-akinetic effects, and psychosis.
J Neural Transm Suppl. 1991;34:203-10. doi: 10.1007/978-3-7091-9175-0_26.
2
Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia.大脑中的谷氨酸能-多巴胺能平衡。其在运动障碍和精神分裂症中的重要性。
Arzneimittelforschung. 1992 Feb;42(2A):265-8.
3
Abusive stimulation of excitatory amino acid receptors: a strategy to limit neurotoxicity.
FASEB J. 1990 Jul;4(10):2789-97. doi: 10.1096/fasebj.4.10.2165013.
4
Ganglioside-mediated protection from glutamate-induced neuronal death.
Acta Neurobiol Exp (Wars). 1990;50(4-5):475-88.
5
Calcium and glutamate-induced cortical neuronal death.
Res Publ Assoc Res Nerv Ment Dis. 1993;71:23-34.
6
Does modulation of glutamatergic function represent a viable therapeutic strategy in Alzheimer's disease?调节谷氨酸能功能是否代表一种治疗阿尔茨海默病的可行策略?
Biol Psychiatry. 1992 Feb 15;31(4):337-50. doi: 10.1016/0006-3223(92)90227-q.
7
Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality.谷氨酸能神经传递调节与非典型抗精神病药物的作用机制
Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1113-23. doi: 10.1016/j.pnpbp.2003.09.007.
8
A metabotropic glutamate receptor agonist does not mediate neuronal degeneration in cortical culture.代谢型谷氨酸受体激动剂不会介导皮质培养物中的神经元变性。
Brain Res. 1991 Oct 11;561(2):338-43. doi: 10.1016/0006-8993(91)91613-6.
9
Schizophrenia: a subcortical neurotransmitter imbalance syndrome?精神分裂症:一种皮质下神经递质失衡综合征?
Schizophr Bull. 1990;16(3):425-32. doi: 10.1093/schbul/16.3.425.
10
Glutamate transmission and toxicity in Alzheimer's disease.阿尔茨海默病中的谷氨酸传递与毒性
Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(4):421-30. doi: 10.1016/0278-5846(88)90102-9.

引用本文的文献

1
The Function of the Mitochondrial Calcium Uniporter in Neurodegenerative Disorders.线粒体钙单向转运体在神经退行性疾病中的作用
Int J Mol Sci. 2017 Feb 10;18(2):248. doi: 10.3390/ijms18020248.
2
Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review.精神分裂症中丘脑的谷氨酸能异常:一项系统综述。
J Neural Transm (Vienna). 2008;115(3):493-511. doi: 10.1007/s00702-007-0859-5. Epub 2008 Feb 26.
3
Comparison of the anticonvulsive activities of organic mono- and dications with their abilities to inhibit NMDA and AMPA glutamate receptors.
有机单阳离子和双阳离子的抗惊厥活性与其抑制NMDA和AMPA谷氨酸受体能力的比较。
Neurosci Behav Physiol. 2004 Feb;34(2):181-7. doi: 10.1023/b:neab.0000009212.61235.ed.
4
Neuroprotective strategies in Parkinson's disease : an update on progress.帕金森病的神经保护策略:进展更新
CNS Drugs. 2003;17(10):729-62. doi: 10.2165/00023210-200317100-00004.